Bath & Body Works (NYSE:BBWI) Price Target Raised to $57.00 at Deutsche Bank Aktiengesellschaft

Bath & Body Works (NYSE:BBWIFree Report) had its price target increased by Deutsche Bank Aktiengesellschaft from $53.00 to $57.00 in a research note released on Monday.

A number of other analysts have also recently weighed in on BBWI. UBS Group raised their price target on Bath & Body Works from $46.00 to $52.00 and gave the company a neutral rating in a research note on Monday, March 4th. JPMorgan Chase & Co. upgraded shares of Bath & Body Works from an underweight rating to a neutral rating and boosted their price objective for the stock from $40.00 to $53.00 in a research report on Friday, May 17th. Piper Sandler increased their target price on shares of Bath & Body Works from $44.00 to $45.00 and gave the company a neutral rating in a research report on Tuesday, April 9th. The Goldman Sachs Group boosted their price target on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a buy rating in a research report on Monday, March 4th. Finally, TD Cowen raised their price objective on Bath & Body Works from $35.00 to $55.00 and gave the stock an outperform rating in a report on Friday, March 1st. Eight analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of Hold and a consensus price target of $48.20.

Get Our Latest Analysis on Bath & Body Works

Bath & Body Works Trading Down 0.3 %

Shares of NYSE:BBWI opened at $51.81 on Monday. The company has a market cap of $11.59 billion, a PE ratio of 13.46, a P/E/G ratio of 1.67 and a beta of 1.90. The company’s 50 day moving average is $47.27 and its two-hundred day moving average is $43.91. Bath & Body Works has a 52 week low of $27.30 and a 52 week high of $52.99.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 21st. Shareholders of record on Friday, June 7th will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 1.54%. The ex-dividend date of this dividend is Friday, June 7th. Bath & Body Works’s payout ratio is 20.78%.

Insider Transactions at Bath & Body Works

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of the company’s stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total value of $209,493.65. Following the sale, the insider now owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.27% of the company’s stock.

Institutional Trading of Bath & Body Works

Several institutional investors and hedge funds have recently made changes to their positions in BBWI. Barclays PLC raised its position in shares of Bath & Body Works by 12.4% in the third quarter. Barclays PLC now owns 637,832 shares of the company’s stock valued at $21,557,000 after buying an additional 70,289 shares during the last quarter. Metis Global Partners LLC grew its stake in Bath & Body Works by 20.5% in the 3rd quarter. Metis Global Partners LLC now owns 8,179 shares of the company’s stock worth $276,000 after acquiring an additional 1,394 shares during the period. New York State Common Retirement Fund raised its holdings in Bath & Body Works by 157.2% in the 3rd quarter. New York State Common Retirement Fund now owns 589,686 shares of the company’s stock valued at $19,931,000 after acquiring an additional 360,445 shares during the last quarter. Oppenheimer Asset Management Inc. purchased a new position in shares of Bath & Body Works during the 3rd quarter worth $1,550,000. Finally, New York Life Investment Management LLC boosted its holdings in shares of Bath & Body Works by 30.3% during the third quarter. New York Life Investment Management LLC now owns 56,338 shares of the company’s stock worth $1,904,000 after purchasing an additional 13,091 shares during the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Featured Articles

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.